Journal profile · Public, Environmental & Occupational Health
Cancer Causes & Control
ISSN 0957-5243 · eISSN 1573-7225 · Springer International Publishing · NETHERLANDS · Monthly · Founded 1990
Cancer Causes & Control: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.19; hybrid open access; APC about USD 3,890; median 123 days to acceptance (103 articles, last 24 months); community-reported acceptance: about 25%; 148 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cancer Causes & Control is published by Springer International Publishing and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Global Cancer Incidence and Screening, Cancer Risks and Factors and Colorectal Cancer Screening and Detection, together about 38.9% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Cancer Causes & Control is an international refereed journal that both reports and stimulates new avenues of investigation into the causes, control, and subsequent prevention of cancer. By drawing together related information published currently in a diverse range of biological and medical journals, it has a multidisciplinary and multinational approach. The scope of the journal includes: variation in cancer distribution within and between populations; factors associated with cancer risk; preventive and therapeutic interventions on a population scale; economic, demographic, and health-policy implications of cancer; and related methodological issues. The emphasis is on speed of publication. The journal will normally publish within 30 to 60 days of acceptance of manuscripts. Cancer Causes & Control publishes Original Articles, Reviews, Commentaries, Opinions, Short Communications and Letters to the Editor which will have direct relevance to researchers and practitioners working in epidemiology, medical statistics, cancer biology, health education, medical economics and related fields. The journal also contains significant information for government agencies concerned with cancer research, control and policy. Editor Emeritus Graham A. Colditz, MD, DrPH, Washington University in St. Louis, St. Louis, Missouri, USA Edward Giovannucci, MD, ScD, Harvard School of Public Health, Boston, Massachusetts, USA
From the journal's Aims & Scope
Research area (LetPub): Public, Environmental & Occupational Health
Editor-in-chief Immaculata De VivoPublisher website
Editorial board by country: none in mainland China; most named India 2, Hong Kong, China 1, Taiwan, China 1, Australia 1, Greece 1 (8 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Global Cancer Incidence and ScreeningMedicine16.2%
- Cancer Risks and FactorsMedicine15.4%
- Colorectal Cancer Screening and DetectionMedicine7.2%
- Nutritional Studies and DietMedicine5.9%
- Cervical Cancer and HPV ResearchMedicine4.3%
- Cancer survivorship and careMedicine4.1%
- BRCA gene mutations in cancerBiochemistry, Genetics and Molecular Biology3.4%
- Carcinogens and Genotoxicity AssessmentBiochemistry, Genetics and Molecular Biology3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Public, Environmental & Occupational Health | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
| Minor | Public, Environmental & Occupational Health | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Public, Environmental & Occupational Health | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.19LetPub ·
- Impact factor (publisher) 2025
- 2.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.5Publisher website ·
- CiteScore 2026-06
- 4LetPub ·
- SJR 2026-06
- 0.98LetPub ·
- SNIP 2026-06
- 0.84LetPub ·
- h-index
- 125LetPub ·
- h-index
- 177OpenAlex ·
- i10-index
- 3,602OpenAlex ·
- 2-year mean citedness
- 1.39OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 36.73%LetPub ·
Volume
- Articles per year
- 148LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 729,700Publisher website ·
Articles by year OpenAlex count · 5,057 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 157 | 95 | 25 |
| 2025 | 148 | 80 | 174 |
| 2024 | 113 | 66 | 381 |
| 2023 | 170 | 108 | 1,030 |
| 2022 | 138 | 87 | 1,323 |
| 2021 | 155 | 96 | 2,199 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
123 daysMedian, submission to acceptance · P25–P75 76 days – 184 days
- Acceptance to online
- median 16 days (103 articles)
- Submission to online
- median 149 days
- Sample
- 103 articles with submission and acceptance dates (333 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 6.6 monthsLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,890 / EUR 2,990 / GBP 2,590 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Page charges
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers2, by deadline
Publisher websiteWhat to prepare8 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 5,000 words
- Reference style
- Numbered, in order of citation
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required, 3
- Cover letter
- Required
Article types accepted12, with length limits
- book reviewCancer Causes & Control: publishes the following article types: Research,Reviews,Brief Report,Comment,Correspondence,Book Reviews Original Research articles sho…main text ≤ 5,000 words
- book reviewsCancer Causes & Control: publishes the following article types: Research, Reviews, Brief Report, Comment, Correspondence, Book ReviewsLength not stated
- brief reportCancer Causes & Control: publishes the following article types: Research,Reviews,Brief Report,Comment,Correspondence,Book Reviews Original Research articles sho…Length not stated
- commentCancer Causes & Control: publishes the following article types: Research, Reviews, Brief Report, Comment, Correspondence, Book ReviewsLength not stated
- correspondenceCancer Causes & Control: publishes the following article types: Research,Reviews,Brief Report,Comment,Correspondence,Book Reviews Original Research articles sho…Length not stated
- letterCancer Causes & Control: publishes the following article types: Research,Reviews,Brief Report,Comment,Correspondence,Book Reviews Original Research articles sho…Length not stated
- meta-analysisCancer Causes & Control: publishes the following article types: Research,Reviews,Brief Report,Comment,Correspondence,Book Reviews Original Research articles sho…Length not stated
- original research articleCancer Causes & Control: publishes the following article types: Research,Reviews,Brief Report,Comment,Correspondence,Book Reviews Original Research articles sho…Length not stated
- researchCancer Causes & Control: publishes the following article types: Research, Reviews, Brief Report, Comment, Correspondence, Book ReviewsLength not stated
- reviewCancer Causes & Control: publishes the following article types: Research,Reviews,Brief Report,Comment,Correspondence,Book Reviews Original Research articles sho…Length not stated
- reviewsCancer Causes & Control: publishes the following article types: Research, Reviews, Brief Report, Comment, Correspondence, Book ReviewsLength not stated
- systematic reviewCancer Causes & Control: publishes the following article types: Research,Reviews,Brief Report,Comment,Correspondence,Book Reviews Original Research articles sho…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
Author Contribution information and Competing Interest information must be provided at submission via the submission interface. Model summary
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data Availability
All original research must include a Data Availability Statement. Model summary
All original research must include a Data Availability Statement. Data Availability Statements should provide information on where data supporting the results reported in the article can be found. Statements should include, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. When it is not possible to share research data publicly, for instance when in…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
Research involving human or animal subjects must include a statement confirming approval (or exemption) by the appropriate institutional and/or national research ethics committee. Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Cancer Causes & Control, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Authors must suggest a minimum of 3 reviewers in the Cover Letter when submitting their manuscript for any article type. Model summary
Authors must suggest a minimum of 3 reviewers in the Cover Letter when submitting their manuscript for any article type.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer International Publishing
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Monthly
- Founded
- 1990
- ISSN
- 0957-5243
- Electronic ISSN
- 1573-7225
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Cancer Causes & Control
What CAS zone is Cancer Causes & Control in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cancer Causes & Control is in Zone 3 of Medicine, and in Zone 3 of the minor category Public, Environmental & Occupational Health / Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cancer Causes & Control?
The latest impact factor listed by LetPub is 2.19; CiteScore 4, h-index 177.
How long does peer review take at Cancer Causes & Control?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 123 days (interquartile range 76–184 days); authors report an average review time of about 6.6 months; the community-reported acceptance is “about 25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cancer Causes & Control?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 5,000 words; Reference style: Numbered, in order of citation; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required, 3; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Cancer Causes & Control based?
Of the 8 board members whose country the journal's board page names, none are in mainland China; the countries named most often are India (2), Hong Kong, China (1) and Taiwan, China (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Cancer Causes & Control?
According to LetPub and DOAJ records, Cancer Causes & Control is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Cancer Causes & Control open access, and what is the APC?
Cancer Causes & Control is a hybrid journal. For open-access publication: APC about USD 3,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .